INSIDERFilingvia Quantisnow
Ikena Oncology Inc. logo

Ikena Oncology (IKNA) director Hughes received 17,520 Stock Option (Right to Buy)

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Owen Hughes (director at Ikena Oncology Inc., IKNA) reported that they received 17,520 Stock Option (Right to Buy) on Jun 9, 2023.

Reporting person
Hughes Owen

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 9, 2023Grant or award (A)Stock Option (Right to Buy)On 17,520 Common Stock1+17,520--17,520 direct

Holdings before and after

  • Stock Option (Right to Buy): 0 to 17,520 direct

Footnotes from the filing

  1. 1. This option shall vest in full upon the earlier of (i) June 9, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Hughes report in this IKNA Form 4?

Owen Hughes (director at Ikena Oncology Inc., IKNA) reported that they received 17,520 Stock Option (Right to Buy) on Jun 9, 2023.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for IKNA

Earlier insider filings at IKNA

Quantisnow market dataNASDAQ
Ikena Oncology Inc. logo
IKNA
Ikena Oncology Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2021
Get push alerts for IKNA

Follow IKNA and get a push notification the moment its next story breaks.

Full IKNA profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IKNA (Ikena Oncology Inc.) and more on Quantisnow.